Elarcosa, Baby Girl .

HRN: 29-32-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/21/2026
07/28/2026
IV
40
Q 24
PSNB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: